Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION
NCT07388030
Arterial Occlusive Diseases, Arteriosclerosis
Shenyang, Liaoning, China
View Trial DetailsNCT Number: NCT07808593
This retrospective, non-interventional study externally validates a pre-trained open-weight deep-learning algorithm (Swin-UNETR) for the opportunistic quantification of coronary artery calcium (CAC) on non-gated routine chest CT scans acquired at a German academic center, and evaluates the prognostic value of this automated imaging biomarker for cardiovascular risk stratification. Coronary calcium is an established predictor of cardiovascular risk, but is not routinely quantified on the tens of thousands of non-cardiac chest CTs performed each year. Because existing high-performing AI models were trained almost exclusively on U.S. cohorts, external validation on a European scanner fleet is required to exclude scanner bias (domain shift). The study comprises three linked analytic cohorts: (1) a validation cohort comparing the AI-CAC score against the ECG-gated cardiac CT Agatston reference; (2) a dialysis cohort assessing calcification progression and mortality; and (3) an emergency department cohort assessing short-term cardiovascular events. This is an investigator-initiated trial with no intervention on patients.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
The study analyzes a retrospective cohort of routine clinical CT examinations at University Hospital Cologne. Data originate from the hospital information system and Picture Archiving and Communication System (PACS) and are provided in pseudonymized form via the Medical Data Integration Center (MeDIC), acting as an independent trusted third party; the re-identification key remains under the sole control of MeDIC. Deep-learning inference is performed locally on isolated, access-controlled graphics processing unit (GPU) clusters of the institution (privacy by design / zero data retention); an open-weight model (Swin-UNETR) is used.
Three research questions are addressed in three analytic cohorts:
Extracted data include demographics (age at examination, sex), cardiovascular risk factors and comorbidities (ICD-10), long-term medication, laboratory values, examination metadata (date, scanner manufacturer, kilovolt peak (kVp), slice thickness), and outcome data (mortality, cardiovascular events, readmissions). Statistical analysis uses Spearman correlation, Cohen's kappa and Bland-Altman analysis for method comparison; t-test / Mann-Whitney-U for group differences in progression; and Kaplan-Meier (log-rank) plus multivariable Cox proportional-hazards and logistic regression for outcome prediction. Legal basis: § 6 (1) no. 2 Health Data Use Act of Germany (GDNG) in conjunction with Art. 9 (2) (j) and Art. 89 (1) GDPR (research privilege); no individual consent (disproportionate effort, Art. 14 (5) (b) GDPR). The AI (artificial intelligence) model carries no CE-marking and is used strictly as a research tool; AI-CAC scores are not systematically fed back into clinical care.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At the index non-contrast chest CT (Day 0) and at the paired ECG-gated cardiac CT obtained within 12 months after the index CT.
Agreement between the automatically extracted AI-CAC score from the non-gated chest CT and the reference Agatston score from a paired ECG-gated cardiac CT, reported as Spearman correlation coefficient, Cohen's kappa across established risk classes (0, 1-100, 101-400, > 400), and Bland-Altman limits of agreement; supplemented by sensitivity, specificity, positive predictive value(PPV)/negative predictive value(NPV) and F1 score
Time frame: From the index non-contrast chest CT (Day 0) through the last available serial non-gated chest CT and the end of individual follow-up, up to 10 years per participant.
Difference in the mean annual increase in AI-CAC between hemodialysis patients (dialysis cohort) and matched kidney-healthy controls measured on serial non-gated CTs (t-test / Mann-Whitney-U), and all-cause mortality analyzed by Kaplan-Meier (log-rank) and multivariable Cox proportional-hazards models (hazard ratios adjusted for confounders
Time frame: 12 months after the index emergency department visit
Occurrence of in-hospital Major Adverse Cardiovascular Events (myocardial infarction, stroke, resuscitation) or cardiovascular readmission within 12 months of the index Emergency Department visit, in relation to an unrecognized high AI calcium score (> 400); reported as adjusted odds ratios and hazard ratios from logistic regression and Cox models
Time frame: At the index non-contrast chest CT (Day 0)
Inference time per case and technical feasibility of running the open-weight deep-learning model (Swin-UNETR) as an isolated container on the institution's local GPU infrastructure
Contact information is provided by the study sponsor or research team.
Carsten Gietzen, MD
CONTACT
Cem Özel, MD
CONTACT
University of Cologne
Other
Opportunistic Screening of Coronary Artery Calcium on Non-Gated Routine Chest CT Using Artificial Intelligence: Retrospective External Validation and Clinical Risk Stratification
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07388030
Arterial Occlusive Diseases, Arteriosclerosis
Shenyang, Liaoning, China
View Trial DetailsNCT07444346
Arterial Occlusive Diseases, Arteriosclerosis
Nanjing, Jiangsu, China
View Trial DetailsNCT06885177
Arterial Occlusive Diseases, Arteriosclerosis
Scottsdale, Arizona, United States
View Trial DetailsNCT06565793
Angina Pectoris, Angina, Unstable
Saint-Denis, France
View Trial Details